Back to Treatments

Treatment

Lecanemab

1
Conditions
26
Trials
3,000
Participants
50%
Average Safety

Condition Evidence

Alzheimer's Disease

26 trials · 3,000 participants

55% effectiveness · 50% safety
Lecanemab | DFDA